Urology billing spans office-based procedures, complex surgeries, in-office drug administration, and high-cost oncology drugs — with one of the most complex modifier landscapes in outpatient care. We handle every code, every component, every payer rule.
Common Billing Challenges
These are the billing failure points we see most often in urology practices — and the ones our team resolves systematically from day one.
Diagnostic cystoscopy (52000) vs. cystoscopy with biopsy (52204) vs. cystoscopy with fulguration (52234-52240) are distinct codes. Same-day cystoscopy + biopsy + fulguration combinations require careful modifier application to avoid bundling denials.
Urodynamic studies include multiple components: cystometrogram (51726/51727), uroflowmetry (51736), EMG (51784), and voiding pressure studies (51797). Each is separately billable — but payers apply CCI edits that frequently bundle components incorrectly.
In-office testosterone injections (J1060 for testosterone cypionate, J3140 for testosterone undecanoate) require dose-matched unit billing and NDC reporting. Formulary restrictions vary dramatically between commercial payers.
Transurethral resection of the prostate (52601, 52630) carries a 90-day global period. Postoperative visits, urethral dilations, and catheter care within the global period require modifier 78 (return to OR) or modifier 79 (unrelated procedure) to be separately billable.
Prostate biopsy (55700) increasingly requires prior authorization — particularly MRI-guided fusion biopsy (55706). Documentation package must include PSA trend, DRE findings, and MRI report (for fusion cases) to meet payer medical necessity criteria.
Bladder cancer drug administration (J9031 for BCG, J9291 for mitomycin) requires accurate drug units, drug cost documentation, and administration code pairing. Payers apply strict waste documentation requirements for high-cost bladder instillation drugs.
Key Procedure Codes
Our coders hold specialty-specific credentials and train continuously on the codes that drive the most revenue — and the most denials — in urology.
| CPT Code | Description | Common Issue |
|---|---|---|
| 52000 | Cystoscopy, diagnostic | Base code; separate with biopsy (52204) or fulguration |
| 51726 | Cystometrogram, complex | CCI edits bundle with 51784 — modifier 59 required |
| 52601 | TURP, complete | 90-day global; post-op separately billable with mod 78/79 |
| 55700 | Prostate biopsy, needle | Prior auth increasingly required; MRI-guided = 55706 |
| J9031 | BCG live intravesical | Dose units must match vial administered; wastage documented |
| J1060 | Testosterone cypionate injection | NDC required; commercial formulary restrictions frequent |
Why RCMAXIS
We are not a generalist billing service that added a specialty module. Our team is built around specialty-specific expertise.
CCI edits for cystoscopy combinations are among the most complex in outpatient urology — our coders know every valid combination and required modifier.
J-code billing for testosterone, BCG, mitomycin, and other in-office drugs includes NDC reporting, dose-matched units, and drug cost documentation.
90-day global periods for TURP and other urologic surgeries are tracked with automatic modifier alerts for separately billable post-op services.
Prostate biopsy and MRI-guided fusion auth packages are prepared proactively with all required clinical documentation.
Full component billing for urodynamic studies with modifier application to prevent CCI bundling denials.
Bladder cancer drug administration workflow includes prior auth, waste documentation, and payer-specific NDC reporting requirements.
Free revenue assessment for qualified practices. We audit your last 90 days of claims, identify every revenue leak, and show you a clear path to better collections — at no cost.